Benzanilide-biphenyl replacement: A bioisosteric approach to quinoline carboxamide-type ABCG2 modulators

ACS Medicinal Chemistry Letters

Volumn 4, Issue 4, 2013, Pages 393-396

  Ochoa Puentes, Cristian ^a,b   Bauer, Stefanie ^a   Kühnle, Matthias ^a   Bernhardt, Günther ^a   Buschauer, Armin ^a   König, Burkhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

ABC transporter; breast cancer resistance protein; MCF 7 cells; solid phase synthesis; Suzuki coupling

Indexed keywords

BIPHENYL DERIVATIVE; BREAST CANCER RESISTANCE PROTEIN; HOE 33342; MULTIDRUG RESISTANCE PROTEIN 1; QUINOLINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; SUZUKI REACTION;

EID: 84876252314     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml4000832     Document Type: Article

References (15)

1. Han, B.; Zhang, J. T. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2 Curr. Med. Chem. Anticancer Agents 2004, 4 (1) 31-42
2. Gottesman, M. M.; Fojo, T.; Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2002, 2 (1) 48-58
3. Fellner, S.; Bauer, B.; Miller, D. S.; Schaffrik, M.; Fankhänel, M.; Spruss, T.; Bernhardt, G.; Graeff, C.; Färber, L.; Gschaidmeier, H.; Buschauer, A.; Fricker, G. Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo J. Clin. Invest. 2002, 110 (9) 1309-1318
4. Hubensack, M.; Müller, C.; Höcherl, P.; Fellner, S.; Spruss, T.; Bernhardt, G.; Buschauer, A. Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice J. Cancer Res. Clin. Oncol. 2008, 134 (5) 597-607
5. Breedveld, P.; Beijnen, J. H.; Schellens, J. H. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs Trends Pharmacol. Sci. 2006, 27 (1) 17-24
6. Rabindran, S. K.; Ross, D. D.; Doyle, L. A.; Yang, W.; Greenberger, L. M. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein Cancer Res. 2000, 60 (1) 47-50
7. Allen, J. D.; Loevezijn, A. v.; Lakhai, J. M.; Valk, M. v. d.; Tellingen, O. v.; Reid, G.; Schellens, J. H. M.; Koomen, G.-J.; Schinkel, A. H. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C Mol. Cancer Ther. 2002, 1, 417-425
8. de Bruin, M.; Miyake, K.; Litman, T.; Robey, R.; Bates, S. E. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR Cancer Lett. 1999, 146 (2) 117-126
9. Robey, R. W.; Steadman, K.; Polgar, O.; Morisaki, K.; Blayney, M.; Mistry, P.; Bates, S. E. Pheophorbide a is a specific probe for ABCG2 function and inhibition Cancer Res. 2004, 64 (4) 1242-1246
10. Kannan, P.; Telu, S.; Shukla, S.; Ambudkar, S. V.; Pike, V. W.; Halldin, C.; Gottesman, M. M.; Innis, R. B.; Hall, M. D. The ″specific″ P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2) ACS Chem. Neurosci. 2011, 2 (2) 82-89
11. Kühnle, M.; Egger, M.; Müller, C.; Mahringer, A.; Bernhardt, G.; Fricker, G.; König, B.; Buschauer, A. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar J. Med. Chem. 2009, 52, 1190-1197
12. Puentes, C. O.; Höcherl, P.; Kühnle, M.; Bauer, S.; Bürger, K.; Bernhardt, G.; Buschauer, A.; König, B. Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2) Bioorg. Med. Chem. Lett. 2011, 21, 3654-3657
13. Kühnle, M. Experimental Therapy and Detection of Glioblastoma: Investigation of Nanoparticles, ABCG2 Modulators and Optical Imaging of Intracerebral Xenografts. Doctoral thesis, University of Regensburg, 2010. http://epub.uni-regensburg.de/13008/.
14. Pizzirani, D.; Roberti, M.; Cavalli, A.; Grimaudo, S.; Cristina, A. D.; Pipitone, R. M.; Gebbia, N.; Tolomeo, M.; Recanatini, M. Antiproliferative agents that interfere with the cell cycle at the G1 S transition: further development and characterization of a small library of stilbene-derived compounds ChemMedChem 2008, 3, 345-355
15. Höcherl, P. New Tariquidar-Like ABCB1 Modulators in Cancer Chemotherapy: Preclinical Pharmacokinetic/Pharmacodynamic Investigations and Computational Studies. Doctoral thesis, University of Regensburg, 2010. http://epub.uni-regensburg.de/15219/.